Signaling through the adaptor molecule MyD88 in CD4(+) T cells is required to 
overcome suppression by regulatory T cells

Schenten, Dominik; Nish, Simone A.; Yu, Shuang; Yan, Xiting; Lee, Heung Kyu; Brodsky, Igor; Pasman, Lesley; Yordy, Brian; Wunderlich, F. Thomas; Brüning, Jens C.; Zhao, Hongyu; Medzhitov, Ruslan

doi:10.1016/j.immuni.2013.10.023

Datensatz

DATENSATZ AKTIONENEXPORT

DownloadE-Mail

Bitte beachten Sie, dass eine neuere Version dieses Datensatzes verfügbar ist:
https://pure.mpg.de/pubman/item/item_2155458_2

DetailsÜbersicht

Signaling through the adaptor molecule MyD88 in CD4(+) T cells is required to overcome suppression by regulatory T cells

Schenten, D., Nish, S. A., Yu, S., Yan, X., Lee, H. K., Brodsky, I., et al. (2014). Signaling through the adaptor molecule MyD88 in CD4(+) T cells is required to overcome suppression by regulatory T cells. Immunity, 40(1), 78-90. doi:10.1016/j.immuni.2013.10.023.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D905-4 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D906-2

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Schenten, Dominik¹, Autor
Nish, Simone A.¹, Autor
Yu, Shuang¹, Autor
Yan, Xiting¹, Autor
Lee, Heung Kyu¹, Autor
Brodsky, Igor¹, Autor
Pasman, Lesley¹, Autor
Yordy, Brian¹, Autor
Wunderlich, F. Thomas², Autor
Brüning, Jens C.³, Autor
Zhao, Hongyu¹, Autor
Medzhitov, Ruslan¹, Autor

Affiliations:
1[ 1 ] Yale Univ, Dept Immunobiol, New Haven, CT 06519 USA [ 2 ] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06519 USA [ 3 ] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA [ 4 ] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, CMMC, Inst Genet, D-50931 Cologne, Germany, ou_persistent22
2Obesity and Cancer, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149645
3Neuronal Control of Metabolism, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149644